Find Drug Costs and Negotiated Prices
drug_money_drugLook up Part D drugs in the Medicare Drug Money Register by a substring of a brand or generic name as CMS prints it, or of a negotiated drug's name as CMS lists it, optionally limited to one period the data carries (a year, YYYY, from CMS's annual file, or a preliminary period, YYYY or a quarter such as 2026Q1, from its quarterly file). Returns up to 10 brands, each with gross drug cost and claims by period, the gross cost per prescription for the preliminary periods (computed by the register from CMS's file, labelled as such) and its change, beside CMS's net estimate or the stated absence of one; for a drug CMS selected for negotiation, its cycle, CMS's negotiated prices by effective date from CMS's file, the discount from list price CMS's fact sheet prints, any deselection and the register's flag where the claims sit outside CMS's band; any White House sheet that names the drug (its direct-purchase prices are never shown); and the labelers rolled up to a parent that carry the brand, as CMS prints them, with the parent and the reviewed table's reason. Co-marketed drugs stay under the labeler CMS prints, and cost is never split or reassigned. Labelers are named as CMS prints them; a parent company comes only from the register's published, reviewed table, with the reason for each mapping. Each figure is named in its record's own words: "gross drug cost" (CMS), CMS's negotiated prices ("negotiated prices, which the statute refers to as maximum fair prices"), "announced an agreement" (the White House), "ad valorem duty rate" (the proclamation) and CMS's "estimated savings". Gross is never net: gross drug cost is before manufacturers' rebates, which CMS may not publish, so a lower gross cost per prescription is never called a saving; CMS's own net estimate is shown beside every claims-based price figure, or the answer says that CMS gives none. Annual years come from CMS's annual file; the later periods come from its preliminary quarterly file, are labelled preliminary and are never put in one series with the annual years. Every answer carries the register's question note: these records show Medicare's gross drug costs as CMS reports them, CMS's negotiated prices and estimates, and the government's announcements and proclamations; they do not show rebates paid, what any company agreed to beyond the published texts, or why any price or agreement was set. Every answer also carries the side-by-side caption, the as-of date, each file's date, the source page on morvs.ai and the data's licence. Institutions only: no prescriber, physician, official, signer or member of Congress is named; labeler strings that read as a person's name are withheld and appear only as counts. A name that matches only a withheld string answers exactly like a name that matches nothing. No party label is given.
Input Schema
| Name | Required | Description | Default |
|---|---|---|---|
| name | Yes | Required case-insensitive substring of a Part D brand or generic name as CMS prints it, or a negotiated drug, for example Eliquis; at most 80 characters. | |
| period | No | Optional period the data carries: a year (YYYY) from the CMS annual file, or YYYY or YYYYQn (e.g. 2026Q1) from its preliminary file; all when omitted. |